Latest Insulin therapy Stories
Investigators from Beth Israel Deaconess Medical Center (BIDMC) in Boston, published a paper in the current issue of the The American Journal of Medicine detailing how marijuana users had significantly lower fasting insulin and were less likely to be insulin resistant than those who did not smoke the weed.
Newly-developed nanoscale particles could be injected into the bodies of diabetic patients, triggering insulin release when glucose levels rise, maintaining normal blood sugar levels for at least a week.
The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus.
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...